Use of polymyxin as an endotoxin blocker in the prevention of diffuse lamellar keratitis in an animal model

Douglas W. Morck, Simon P. Holland, Howard Ceri, Robert Hancock, Monisha Scott-Gough, Van Nugyen, Erin J. Keith, Tracy L. Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)


PURPOSE: To determine whether bacterial endotoxin, lipopolysaccharide (LPS), could induce diffuse lamellar keratitis (DLK) in an animal model and whether DLK could be prevented by endotoxin blockers such as polymyxin. METHODS: Laser in situ keratomileusis (LASIK) flaps were created in rabbit eyes. The stromal bed was treated with 20 μg of Burkholderia cepacia LPS or balanced salt solution (BSS). Development of DLK, histological degree of inflammation, and presence of LPS detected by anti-LPS antibody were evaluated after 48 hours. In a second experiment, all eyes received LPS and were randomly assigned to receive either polymyxin in the form of two drops of Polytrim (Allergan, Irvine, Calif) on the stromal bed or two drops of BSS. RESULTS: In the animal model study, LPS was significantly associated with the development of DLK (P<.05, n=30). Infiltration with polymorphonuclear cells and presence of DLK were found in LPS treated eyes but not in controls. In the second experiment, 4 (27%) of 15 eyes that received polymyxin in addition to LPS developed DLK compared to 18 (95%) of 19 eyes that received only LPS (P<.05, n=34). There was a trend towards higher flap displacement in polymyxin treated eyes but this was not significant (P=.07). CONCLUSIONS: Diffuse lamellar keratitis in a rabbit model can be caused by bacterial endotoxin (LPS). Endotoxin blockers, such as polymyxin, are effective in decreasing the incidence of endotoxin-induced DLK in a rabbit model.

Original languageEnglish
Pages (from-to)152-157
Number of pages6
JournalJournal of Refractive Surgery
Issue number2
Publication statusPublished - 1 Jan 2005
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this